--- title: "Hindustan Oxygen Gas Ltd (509660) — Share Price, Financials & Analysis" symbol: "509660" company: "Hindustan Oxygen Gas Ltd" canonical: "https://tapetide.com/stocks/509660" bse_code: "509660" generated_at: "2026-10-13T11:01:49.301Z" --- # Hindustan Oxygen Gas Ltd (509660) Canonical page: https://tapetide.com/stocks/509660 ## Company - **BSE Code:** 509660 - **Stock Type:** EQUITY - **Face Value:** ₹100 - **F&O Eligible:** No ## Latest Price ## Growth Rates | Metric | 1Y | | --- | --- | | revenue growth | -14% | ## Financial Statements ### Quarterly Results All figures in ₹ crore unless the row name says otherwise. | Item | Sep 2024 | Mar 2025 | Sep 2025 | | --- | --- | --- | --- | | Sales | 55 | 60 | 57 | | Expenses | 48 | 49 | 45 | | Operating Profit | 7 | 11 | 12 | | OPM % | 14 | 18 | 21 | | Other Income | 0 | 0 | 0 | | Interest | 0 | 1 | 1 | | Depreciation | 0 | 1 | 1 | | Profit before tax | 7 | 9 | 11 | | Tax % | 23 | 27 | 25 | | Net Profit | 5 | 7 | 8 | | EPS in Rs | 1660.26 | 5.5 | 6.64 | ### Profit & Loss All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2013 | Mar 2014 | Mar 2015 | | --- | --- | --- | --- | | Sales | 0.13 | 0.14 | 0.12 | | Expenses | 0.21 | 0.25 | 0.31 | | Operating Profit | -0.08 | -0.11 | -0.19 | | OPM % | -61.54 | -78.57 | -158.33 | | Other Income | 0.08 | 0.1 | 0.36 | | Interest | 0 | 0 | 0 | | Depreciation | 0 | 0 | 0.01 | | Profit before tax | 0 | -0.01 | 0.16 | | Tax % | — | 0 | 0 | | Net Profit | 0 | -0.01 | 0.16 | | Dividend Payout % | — | 0 | 0 | ### Balance Sheet All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2013 | Mar 2014 | Mar 2015 | | --- | --- | --- | --- | | Equity Capital | 0.3 | 0.4 | 0.4 | | Reserves | -1.21 | -1.22 | -1.08 | | Borrowings | 0.4 | 0.61 | 0.72 | | Other Liabilities | 0.88 | 0.4 | 0.39 | | Total Liabilities | 0.37 | 0.19 | 0.43 | | Fixed Assets | 0.04 | 0.05 | 0.06 | | CWIP | 0 | 0 | 0 | | Investments | 0.02 | 0.02 | 0.02 | | Other Assets | 0.31 | 0.12 | 0.35 | | Total Assets | 0.37 | 0.19 | 0.43 | ### Cash Flow All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2013 | Mar 2014 | Mar 2015 | | --- | --- | --- | --- | | Cash from Operating Activity | -0.18 | -0.4 | -0.18 | | Cash from Investing Activity | 0.07 | 0.05 | 0.3 | | Cash from Financing Activity | 0.07 | 0.31 | 0.11 | | Net Cash Flow | -0.04 | -0.04 | 0.23 | | Free Cash Flow | -0.18 | -0.4 | -0.23 | | CFO/OP | 225 | 364 | 95 | ### Ratios | Item | Mar 2013 | Mar 2014 | Mar 2015 | | --- | --- | --- | --- | | Debtor Days | 56.15 | 52.14 | 60.83 | | Inventory Days | 121.67 | 182.5 | 81.11 | | Days Payable | 425.83 | 304.17 | 243.33 | | Cash Conversion Cycle | -248.01 | -69.52 | -101.39 | | Working Capital Days | -1628.46 | -756.07 | -882.08 | ## Shareholding Pattern ### annual | Category | Nov 2025 | | --- | --- | | Promoters | 69.02% | | FIIs | 7.65% | | DIIs | 5.51% | | Public | 17.83% | | No. of Shareholders | 905 | ### Quarterly | Category | Nov 2025 | | --- | --- | | Promoters | 69.02% | | FIIs | 7.65% | | DIIs | 5.51% | | Public | 17.83% | | No. of Shareholders | 905 | ## Technical Indicators Derived from daily closing prices and recomputed each trading session; values move with the market. - **Overall Signal:** Strong Sell - **Buy / Neutral / Sell:** 3 / 4 / 12 ### Moving Averages — summary: **Strong Sell** | Indicator | Value | Signal | | --- | --- | --- | | SMA (10) | 869.93 | Sell | | EMA (10) | 874.96 | Sell | | SMA (20) | 913.83 | Sell | | EMA (20) | 900.17 | Sell | | SMA (50) | 965.74 | Sell | | EMA (50) | 959.25 | Sell | | SMA (100) | 1047.28 | Sell | | EMA (100) | 1039.73 | Sell | | SMA (200) | 1200.32 | Sell | | EMA (200) | 1170.62 | Sell | ### Oscillators — summary: **Buy** | Indicator | Value | Signal | | --- | --- | --- | | RSI (14) | 38.36 | Neutral | | MACD (12,26,9) | -32.66 | Sell | | Stochastic (14,3,3) | 11.46 | Buy | | ADX (14) | 16.7 | Neutral | | Williams %R (14) | -86.02 | Buy | | ATR (14) | 40.92 | High Volatility | | ROC (12) | -12.04 | Sell | | Stoch RSI (14) | 15.99 | Buy | | UO (7,14,28) | 49.75 | Neutral | ## Filings & Documents ### Other Documents | Date | Document | | --- | --- | | 2026-02-24 | [Monitoring Agency Report For The Quarter Ended 31 December 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/464e8bc6-32b3-4b32-a3c4-e9538bc74867.pdf) | | 2026-02-24 | [Board Meeting Outcome For Proposed Incorporation Of A Subsidiary Company](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ef832598-05bb-48c3-acfe-6fb2a4afb15d.pdf) | | 2026-02-19 | [Announcement Under Regulation 30 Of SEBI (LODR) - Incorporation Of A Subsidiary Company](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3bc9c369-f70b-40d4-883e-2523da1d1081.pdf) | | 2026-01-12 | [Board Meeting Outcome for Proposed Incorporation Of A Subsidiary Company](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1f81ccd9-5470-4d1a-8165-6a9706612d09.pdf) | | 2025-12-01 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/xml-data/corpfiling/AttachHis/92a04991-a4bb-4609-99e6-a7a66f744c98.pdf) | | 2025-11-25 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/xml-data/corpfiling/AttachHis/678a3aa7-e923-479a-ad02-cfaa92878dea.pdf) | | 2025-11-25 | [Certificate from CEO/CFO](https://www.bseindia.com/xml-data/corpfiling/AttachHis/62540ee0-8b01-47ff-bc1e-596cb049dc05.pdf) | | 2025-11-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/xml-data/corpfiling/AttachHis/038547c0-bd15-4a1f-8766-2dd3c55d9810.pdf) | ### Earnings Call Documents | Date | Document | | --- | --- | | Dec 2025 | [Concall - Dec 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/92a04991-a4bb-4609-99e6-a7a66f744c98.pdf) | --- Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T11:01:49.301Z.